statistiche ricercatore

statistiche per CANOSA, Antonio

Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2000
EU - Europa 1927
AS - Asia 1089
OC - Oceania 24
SA - Sud America 24
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5078
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1933
IT - Italia 743
CN - Cina 597
AT - Austria 245
KR - Corea 240
SE - Svezia 181
FR - Francia 179
DE - Germania 116
FI - Finlandia 95
VN - Vietnam 94
GB - Regno Unito 80
UA - Ucraina 77
CA - Canada 61
PL - Polonia 54
JP - Giappone 52
IN - India 39
ES - Italia 33
UZ - Uzbekistan 27
AU - Australia 22
NL - Olanda 19
BE - Belgio 17
IE - Irlanda 12
TR - Turchia 12
RU - Federazione Russa 11
PT - Portogallo 9
BR - Brasile 8
CO - Colombia 8
CZ - Repubblica Ceca 8
DK - Danimarca 8
GR - Grecia 8
BG - Bulgaria 6
HK - Hong Kong 6
HR - Croazia 6
TW - Taiwan 6
MX - Messico 5
RO - Romania 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
EU - Europa 4
SN - Senegal 4
AR - Argentina 3
IR - Iran 3
PH - Filippine 3
SG - Singapore 3
CH - Svizzera 2
CL - Cile 2
ID - Indonesia 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
UY - Uruguay 2
ZA - Sudafrica 2
BD - Bangladesh 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
IL - Israele 1
IM - Isola di Man 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 5078
Salva come PNG Salva come JPEG
Città #
Beijing 343
Torino 290
Vienna 241
Fairfield 233
Houston 157
Ann Arbor 136
Wilmington 125
Villeurbanne 114
Jacksonville 112
Woodbridge 108
Seattle 98
Ashburn 95
Cambridge 86
Redwood City 83
Fremont 57
Dearborn 55
Dong Ket 54
Warsaw 51
Pisa 45
Hangzhou 37
Chengdu 29
Milan 24
Toronto 23
Seoul 18
Cervignano Del Friuli 17
Hebei 16
Shanghai 16
Ottawa 14
San Diego 13
Tokyo 13
Chicago 12
Nanjing 12
Hefei 11
Guangzhou 10
Mountain View 10
Rome 10
Duncan 9
Genova 9
Guiyang 9
Kunming 9
Paris 9
Falls Church 8
Norwalk 8
Padova 8
Silver Spring 8
Bethesda 7
Xian 7
Zhengzhou 7
Bologna 6
Detroit 6
Fuzhou 6
Limoges 6
Munich 6
Oxford 6
Phoenix 6
Portadown 6
Salerno 6
Waanrode 6
Wuhan 6
Buffalo 5
Nanchang 5
Napoli 5
New York 5
Nürnberg 5
Prague 5
Riverton 5
Taipei 5
Barnsley 4
Castelnuovo Rangone 4
Central District 4
Dresden 4
Hamburg 4
Hanoi 4
Jinan 4
Las Vegas 4
Philadelphia 4
San Mateo 4
Sarajevo 4
Shenyang 4
Sofia 4
Stony Brook 4
Sydney 4
Algeciras 3
Aurora 3
Baltimore 3
Binasco 3
Boston 3
Cagliari 3
Dallas 3
Edinburgh 3
Erlangen 3
Lanzhou 3
Lentini 3
Leuven 3
Madrid 3
New Haven 3
Olgiate Molgora 3
Palermo 3
Pasadena 3
Québec 3
Totale 3086
Salva come PNG Salva come JPEG
Nome #
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study 435
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. 354
Acoustic reflex patterns in amyotrophic lateral sclerosis 230
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. 158
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 158
Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor. 131
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 130
Validation of the revised classification of cognitive and behavioural impairment in ALS 124
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring 119
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 118
Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta register 112
Acute, Hemorrhagic, Necrotizing Pancreatitis Associated With Riluzole Treatment in a Patient With Amyotrophic Lateral Sclerosis 112
Spatial epidemiology of Amyotrophic Lateral Sclerosis in Piedmont and Aosta Valley, Italy: a population-based cluster analysis 97
The multistep hypothesis of ALS revisited: The role of genetic mutations 95
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome? 87
Does Recognition of Facial Expression of Primary and Social Emotions in ASL Patients Interfere with Social Competence? 84
Can eye-tracking system communication improve quality of life and mood in ALS patients with locked-in syndrome 82
Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls 81
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. 80
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 79
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 74
Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis 73
Expression of NOX2 protein in neutrophils of patients with ALS 71
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 69
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms 69
Cognitive impairment across ALS clinical stages in a population-based cohort 61
Lithium carbonate does not prevent ALS: a case-report of four patients on long-term therapy for the treatment of bipolar disorder 59
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 59
NADPH oxidase (NOX2) activity is a modifier of survival in ALS 58
Monocytes of patients with Amyotrophic Lateral Sclerosis linked to gene mutations display altered TDP-43 subcellular distribution 57
Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study 53
ALS clinical trials: Do enrolled patients accurately represent the ALS population? 51
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. 50
Does Recognition of Facial Expression of Primary and Social Emotions in ALS Patients Interfere with Social Competence? 49
Influence of cigarette smoking on ALS outcome: A population-based study 48
Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study 48
DETECTING COGNITIVE CHANGES IN ALS: A POPULATION-BASED STUDY 47
18 F-FDG-PET correlates of cognitive impairment in ALS 47
Prognostic influence of pre-morbid smoking habits, diabetes, arterial hypertension and vascular risk profile on phenotype and outcome of ALS patients: a population-based study. 46
Frontotemporal dementia in three cases of familial amyotrophic lateral sclerosis with TARDBP A382T mutation 42
Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study 42
Pain in amyotrophic lateral sclerosis: a population-based controlled study 38
What’s ALS? ALS clinical phenotypes in an Italian register 38
ALS Clinical Trials: Do the Enrolled Patients Represent the ALS Population? 37
UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study 36
A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment. 36
A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course. 34
Monomelic amyotrophy is not always benign: A case report 33
Cognitive Reserve in ALS with Comorbid Frontotemporal Dementia (FTD): A Population-Based Study 33
Genetic architecture of ALS in Sardinia. 33
Pain in ALS: a case-control study 32
Clinical phenotypes in amyotrophic lateral sclerosis: a population-based study in Italy 32
The role of APOE in the occurrence of frontotemporal dementia in amyotrophic lateral sclerosis 31
Religiousness is positively associated with quality of life of ALS caregivers 30
Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene 30
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 30
null 30
Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis 30
ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations 29
Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort 29
An ALS case with a novel D90N-SOD1 heterozygous missense mutation 28
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 28
Validation of the Italian version of self-administered ALSFRS-R scale 28
A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. 27
ALS phenotype is influenced by age, sex, and genetics: A population-based study 27
The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in Amyotrophic Lateral Sclerosis 27
Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic 27
An ALS-FTD Patient Carrying a Double Pathogenetic Mutation of C9ORF72 and TARDBP: Case Report 26
Comorbidity of Cervical Spondylogenic Myelopathy and Amyotrophic Lateral Sclerosis: When Electromyography Makes the Difference in Diagnosis 24
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 24
TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients 24
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience 23
Differential neuropsychological profile of ALS patients with and without C9orf72 mutation 23
Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study 22
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 20
Prospective epidemiological registers: a valuable tool for uncovering ALS pathogenesis 18
Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F-FDG-PET study 18
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 17
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 17
Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort 17
The characteristics of cognitive impairment in als patients depend on the lateralization of motor damage 15
A familial amyotrophic lateral sclerosis pedigree discordant for a novel p.Glu46Asp heterozygous OPTN variant and the p.Ala5Val heterozygous SOD1 missense mutation 14
Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: An 18F-FDG-positron emission tomography stud 14
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 13
Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis 13
Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes 13
Segni e sintomi inusuali o rari in Neurologia 12
Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability 12
A novel splice site FUS mutation in a familial ALS case: effects on protein expression 12
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture 10
Arterial blood gas analysis: base excess and carbonate are predictive of noninvasive ventilation adaptation and survival in amyotrophic lateral sclerosis 10
The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairment 9
Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis 8
Prognostic role of slow vital capacity in amyotrophic lateral sclerosis 8
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis 8
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis 7
Tailoring patients’ enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs 7
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS 7
Neck flexor weakness at diagnosis predicts respiratory impairment in amyotrophic lateral sclerosis 6
What is amyotrophic lateral sclerosis prevalence? 6
Totale 5329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5358
article - articoli 0
book - libri 0
conference - conferenze 789
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6147
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2016/2017174 0000 00 00 0014925
2017/2018835 451117549 3823 2879 239852934
2018/2019711 45453245 3725 51112 366713185
2019/2020944 40353795 40110 12296 1301285556
2020/20211254 84898559 11697 88107 18211557175
2021/20221092 653181135 12179 8974 831741600
Totale 5358
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie-Privacy
Logo CINECA  Copyright © 2022